Andrew T. Parsa, MD, PhD

Yale University, New Haven, Connecticut, B.S., 1984-1988, Molecular Biophysics and Biochemistry
Downstate Medical Center, Brooklyn, New York, Ph.D., 1995, Anatomy and Cell Biology
Downstate Medical Center, Brooklyn, New York, M.D., 1996, Medicine
Columbia University College of Physicians and Surgeons, New York, New York, Residency, 1996-2002, Neurological Surgery

• 2001-2002
  Chief Resident, Department of Neurological Surgery, Columbia University College of Physicians and Surgeons
• 2002
  Assistant Professor, Department of Neurological Surgery, University of California, San Francisco, Principal Investigator, Brain Tumor Research Center, University of California, San Francisco
• 2007
  Khatib Chair in Skull Base Tumor Surgery, University of California, San Francisco

• 1988
  Yale University Summer Research Scholarship Department of Molecular Biophysics and Biochemistry
• 1989
  National Institutes of Health Research Fellowship College of Medicine Downstate Medical Center
• 1990
  National Institutes of Health Research Fellowship College of Medicine Downstate Medical Center
• 1992
  First Prize Alpha Omega Alpha Student Research Symposium College of Medicine Downstate Medical Center
• 1992
  Chandler McCuskey Brooks Award for Best Paper Dean's Day School of Graduate Studies Downstate Medical Center
• 1993
  Research Fellowship Award for Outstanding Scientific Proposal School of Graduate Studies Downstate Medical Center
• 1994
  First Prize Alpha Omega Alpha Student Research Symposium College of Medicine Downstate Medical Center
• 1994
  Award for Distinguished Performance in Research Associated Medical Schools of New York State
• 1995
  Induction into Alpha Omega Alpha Medical Honor Society Eta Chapter College of Medicine Downstate Medical Center
• 1996
  Award for Outstanding Achievement in Clinical Neurology College of Medicine Downstate Medical Center
• 1996
  Graduation with Honors and Distinction in Clinical Research College of Medicine Downstate Medical Center
• 2000
  First Prize and Elsberg Award New York City Society of Neurosurgery Annual Resident Research Competition
• 2000
  Resident Research Award New York State Society of Neurosurgery
• 2000
  House Staff Resident Research Award New York Presbyterian Hospital
• 2001
  Preuss Award Joint Section on Tumors Congress of Neurological Surgeons Annual Meeting, San Diego, California
• 2002
  Academy Award, Honorable Mention, American Academy of Neurological Surgeons, Phoenix, Arizona
• 2003
  Young Clinician Investigator Award, American Association of Neurological Surgeons
• 2003
  Harold Rosegay Teaching Award, UCSF Department of Neurological Surgery
• 2003
  National Brain Tumor Foundation, Translational Research Award
• 2004
  UCSF-Cancer Center Career Development Award
• 2005
  UCSF School of Medicine, Academic Senate Teaching Award Nominee
• 2006
  UCSF Designated Nominee; Damon Runyon Clinical Investigator Awards Program

• Birch BD, Johnson JP, Parsa A, Desai RD, Yoon JT, Lycette CA, Bruce JN. Frequent NF2 gene transcript mutations in sporadic intramedullary spinal cord ependymomas. Neurosurgery 1996; 115:513-518.
• Bruce JN, Falavigna A, Johnson JP, Hall JS, Birch BD, Yoon JT, Wu EX, Fine RL, Parsa AT. Intracerebral clysis in a rat glioma model. Neurosurgery 2000;46:683-691.
• Parsa AT, Fiore A, McCormick PC, and Bruce JN. Genetic basis of intramedullary spinal cord tumors and therapeutic implications. Journal of Neuro-oncology 2000; 47:239-251.
• Parsa AT, Chakrabarti I, Hall JS, Hurley PT, Chi JH, Kaiser MG, Bruce JN. Limitations of the C6/Wistar rat intracerebral glioma model: Implications for evaluating immunotherapy. Neurosurgery 2000; 47: 993-1000.
• Kaiser MG, Parsa AT, Fine RL, Hall JS, Chakrabarti IC, Bruce JN. Tissue distribution and anti-tumor activity of topotecan by intracerebral clysis in a rat glioma model. Neurosurgery 2000; 47: 1391-1399.
• Anderson RC, Elder J, Parsa AT, Issacson S, Sisti M. Radiosurgery for the treatment of recurrent central neurocytomas. Neurosurgery 2001; 48: 1231-1238.
• Parsa AT, Chi J, Hurley PT, Jeyapalan S, Bruce JN. Immunomodulation of glioma cells after gene therapy: Induction of MHC Class I but not Class II antigen in vitro. Neurosurgery 2001; 49: 681-689.
• Anderson RC, Elder JB, Brown MD, Mandigo CE, Parsa AT, Kim PD, Senatus P, Anderson DE, Bruce JN. Changes in the immunologic phenotype of human malignant glioma cells after passaging in vitro. Clin Immunol. 2002 Jan;102(1):84-95.
• Parsa AT, Miller JI, Eggers AE, Anderson RC, Ogden AT, Bruce JN. Autologous adjuvant linked fibroblasts induce anti-glioma immunity: implications for development of a glioma vaccine. Journal of Neurooncology. 2003 Aug-Sept; 64:77-87.
• Sanai N, Tramontin AD, Quinones-Hinojosa A, Barbaro NM, Gupta N, Kunwar S, Lawton MT, McDermott MW, Parsa AT, Manuel-Garcia Verdugo J, Berger MS, Alvarez-Buyalla A. Unique astrocyte ribbon in adult human rain contains neural stem cells but lacks chain migration. Nature. 2004 Feb 19; 427(6976):740-4
• Parsa AT, Lee J, Parney IF, Weinstein P, Ames C. Intradural, extraparenchymal CNS neoplasms: management paradigms. Journal of Neurooncology, 2004 Aug-Sep;69(1-3):291-318
• McDermott MW, Berger MS, Kunwar S, Parsa AT, Sneed PK, Larson DA. Stereotactic radiosurgery and interstitial brachytherapy for glial neoplasms. J Neurooncol. 2004 Aug-Sep;69(1-3):83-100.
• Parsa AT and Holland EC: Translational control of gene expression by oncogenic Ras and Akt: Implications for cancer progression and treatment. Trends in Molecular Medicine 2004 Dec;10(12):607-13
• Parsa AT, Wachorst S, Lamborn KR, Prados MD, Berger MS, Chang SM. Prognostic Significance Of Intracranial Dissemination in Adult Glioblastoma Multiforme. Journal of Neurosurgery,2005 Apr102(4):622-8.
• Panner A, Parsa AT and Pieper R. Translational Regulation of TRAIL Sensitivity. Cell Cycle, 2006 Jan;5(2):147-50
• Senatus PB, Li Y, Mandigo C, Nichols G, Moise G, Mao Y, Brown MD, Anderson RC, Parsa AT,
• Brandt-Rauf PW, Bruce JN, Fine RL. Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptide. Mol Cancer Ther. 2006 Jan;5(1):20-8.